MentionFox
Home › Executive changes › Camp4 Therapeutics Corp
Leadership changes · CAMP · SEC Form 8-K, Item 5.02

Leadership changes at Camp4 Therapeutics Corp (2026)

Before you join, sell to or invest in Camp4 Therapeutics Corp

MentionFox check on Camp4 Therapeutics Corp: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/camp4-therapeutics

Check Camp4 Therapeutics Corp before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Camp4 Therapeutics Corp?

Who joined and who left Camp4 Therapeutics Corp (CAMP)? 1 filing reported on 2026-03-24, each cited to the company's own filing.

As of November 14, 2026, Camp4 Therapeutics Corp has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 24, 2026 (Form 8-K, March 24, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

AH Bio Fund I, L.P. also filed stake reports on 1 other company ↓

Sell to companies like Camp4 Therapeutics Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-03-24

Camp4 Therapeutics Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-24. Every row below is cited to the filing it comes from, and this page adds each new change as Camp4 Therapeutics Corp files it.

Also on the record for Camp4 Therapeutics Corp

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G/A, by Coastlands Capital LP9.99% of the class5%+ stakesSource
November 12, 2026Stake report, Schedule 13G, by Adage Capital Management, L.P.6.68% of the class5%+ stakesSource
November 5, 2026Stake report, Schedule 13G/A, by FMR LLC7.8% of the class5%+ stakesSource
August 31, 2026Stake report, Schedule 13D/A, by 5AM Ventures VI, L.P.9.9% of the class5%+ stakesSource
August 19, 2026Stake report, Schedule 13D/A, by Polaris Management Co. VII, L.L.C.6.3% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by BALYASNY ASSET MANAGEMENT L.P.4.99% of the class5%+ stakesSource
August 10, 2026Stake report, Schedule 13G, by Trails Edge Capital Partners, LP6% of the class5%+ stakesSource
August 5, 2026Stake report, Schedule 13D/A, by 5AM Ventures VI, L.P.9.9% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G, by Balyasny Asset Management L.P.5.07% of the class5%+ stakesSource
March 11, 2026Stake report, Schedule 13D/A, by Enavate Sciences GP, LLC4.8% of the class5%+ stakesSource
February 13, 2026Stake report, Schedule 13G/A, by Vivo Opportunity Fund Holdings, L.P.7.4% of the class5%+ stakesSource
February 5, 2026Stake report, Schedule 13G/A, by FMR LLC9.5% of the class5%+ stakesSource

Selling to them or working with them? See who runs Camp4 Therapeutics Corp now and the warning signs.

Free to see. No signup.

Keep reading

More on Camp4 Therapeutics Corp and the records around it.

Camp4 Therapeutics Corp elsewhere on the record

Companies that share a holder

Want the whole picture on Camp4 Therapeutics Corp?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Camp4 Therapeutics Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Camp4 Therapeutics Corp covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 29 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-03-24Reportednot named in the filing8-K, 2026-03-24
Selling to Camp4 Therapeutics Corp?

New leaders reset buying decisions — get the Full Report on Camp4 Therapeutics Corp: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Camp4 Therapeutics Corp

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Camp4 Therapeutics Corp, with the record behind each one.

Find candidates like senior executive at Camp4 Therapeutics Corp

Every change, in the filing's words

Filed 2026-03-24 · 8-K

Reported

On March 18, 2026, the Board of Directors (the " Board ") of the CAMP4 Therapeutics Corporation (the " Company ") appointed Michael MacLean as a Class III director, effective April 1, 2026 (the " Appointment Date ").

Also stated in this filing

  • Mr. MacLean has also been appointed to the Audit Committee and Compensation Committee of the Board, effective on the Appointment Date.
  • In connection with this director appointment, the Board increased the size of the Board from eight members to nine members.
  • Mr. MacLean, age 60, has over 35 years of financial leadership experience in the biotechnology and life sciences industries, with extensive expertise in public company reporting, capital markets transactions, internal controls, and corporate governance.
  • He most recently served as Chief Financial Officer of Avidity Biosciences, Inc., a publicly traded company, until its acquisition by Novartis, a position he held from May 2020 through April 2026.
  • Mr. MacLean joined Avidity prior to its initial public offering and was responsible for its finance and business functions through its initial public offering and subsequent growth as a multinational organization.
  • He also served as a principal negotiator in connection with the company's acquisition by Novartis and a multi-target cardiology collaboration with Bristol Myers Squibb.
  • Previously, Mr. MacLean served as Chief Financial Officer of Akcea Therapeutics, Inc. from 2017 to 2020 and as Chief Financial Officer of PureTech Health plc from 2015 to 2017.

Tools for this story

Each opens in a new tab, filled in for Camp4 Therapeutics Corp. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/camp4-therapeutics
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Camp4 Therapeutics Corp? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/camp4-therapeutics